MDNews - Cleveland-Akron-Canton

January/February 2019

Issue link: https://viewer.e-digitaledition.com/i/1087790

Contents of this Issue

Navigation

Page 14 of 23

Infection Development in Prosthetic Joints PROSTHE TIC JOINT INFECTION (PJI) may occur within the wound or around the implant itself. It can develop anytime after surgery, and an infection in a patient's body can also spread to a prosthetic joint. However, a PJI in the implant itself poses greater risk to patients than typical infections. "The primary reason [for the increased risk] is there is no blood flow to the prosthesis and the materials that we use," says Richard A. Berg, MD, a physician at Life Bridge Health in Baltimore who was involved in research published in The Lancet in 2015 regarding PJI. "The bacteria can become adherent and make a layer of nondiffusible material around themselves. We call it slime. It impedes one's immune system from effectively attacking the bacteria ... [and] makes it more difficult for them to be cleared." With regard to single- or two-stage surgical treatment of PJI, Dr. Berg believes each case must be approached individually. "I think it altogether depends on what the situation is," he says. "Case selection is absolutely vital for deciding. We can't be sure that we're putting a prosthetic joint in a sterile field." Dr. Berg highlights the importance of preventing infection to begin with, particularly among patients who have diabetes or are obese. "What anybody can do is to optimize the chances of their doing well by making sure they don't have an active rash at the area of the skin, no infection at the place where the wound is going to be placed, and [they are] in the best metabolic shape at the surgery," he says. "This is what you do for any surgery, and if somebody does get an infection, it does often lead to a prolonged course of antibiotics and several more surgeries ... so optimizing the initial surgery lessens the chance of infection." T h e a n t i bi o t i c r e g i m e n a n d t h e oppor tunit y to monitor for complete clea ra nce of infection have led most hospita ls i n t he U. S. a nd t he U. K . to favor the two-stage approach. However, f indings from the University of Bristol study suggest one-stage surger y may be just as effective, if not more so. "For severa l decades, the commonly used t wo -st a ge procedu re ha s been presu med to be more ef fective t ha n the one-sta ge procedure," says Setor K u nu t s or, Ph D (C a nt a b .), M B C h B ( L egon), M A (Ca nt ab.), B A ( L egon), Research Fellow in Evidence Synthesis at the Universit y of Bristol. " The one- sta ge strateg y is less common ly used b e c a u s e of l i m it e d e v idenc e on it s effectiveness. It, however, has potentia l adva ntages, which include having only one major su rger y, a shor ter overa l l s t ay i n t he hospit a l , re duc e d f u nc - tiona l impa irment a nd less ex pense. With these new findings and subsequent adoption of the one-sta ge strateg y by surgeons a nd hospita ls, qua lit y of life could be improved, unnecessar y deaths aver ted, a nd this could a ll be achieved at a lower cost." THE FINDINGS The study, in the European Journal of Epidemiology, a na lyzed re-infection rates a mong 1,856 pa r ticipa nts across f o u r c o n t i n e n t s w h o u n d e r w e n t surger y for prosthetic hip joint infec- tions. At media n follow-up of 3.7 yea rs, 16 . 8 p e r c e nt of on e - s t a ge s u r ge r y patients experienced re-infection, com- pa red w ith 32.3 percent of t wo-sta ge surger y patients. Fur ther resea rch is under way to measure outcomes of both approaches. (See sideba r " IN FOR M Prog ra m a nd Clinica l Tria l.") W h i l e K u n u t s o r b e l i e v e s a d d i - tiona l resea rch w i ll prov ide va luable perspective, he recommends surgeons consider the one-stage strateg y to treat PJI, due to a ra nge of potentia l adva n- ta ges — t he most obv ious being t hat patients undergo only one major surgery. Beswick urges caution in interpreting the data, as patient cha racteristics a nd other factors besides choice of revision strateg y may have a f fected the f ind- ings. Nonetheless, he sees sig nif ica nt potentia l for the one-stage approach. "In a two-stage revision, patients do not have a f u l ly f unctioning hip joint for between two weeks and 12 months," B es w ick say s . "A t empora r y spa cer may be f itted, but patients experience considerable physica l and psychologica l difficulties during this period, and spac- ers are associated with a high incidence of complications ... . W hile the operation in a one-stage revision may be of longer duration, rehabilitation a nd recover y ca n commence immediately." n M D N E W S . C O M /// M D N E W S C l E v E l A N D /A K R O N / C A N T O N ■ J A N U A R Y/ F E B R U A R Y 2 019 1 5

Articles in this issue

Archives of this issue

view archives of MDNews - Cleveland-Akron-Canton - January/February 2019